ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,246, issued on Dec. 2, was assigned to THE TRUSTEES OF INDIANA UNIVERSITY (Bloomington, Ind.).

"Replication protein a (RPA)-DNA interaction inhibitors" was invented by John J. Turchi (Indianapolis) and Navnath Gavande (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to RPA compounds or pharmaceutically acceptable salts thereof, and for the use of the compounds to treat cancer."

The patent was filed on Dec. 10, 2020, under Application No. 17/782,876.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%...